HeartCore Enterprises, Inc.
HTCRNasdaqCIK 1892322TechnologyFiscal year ends Dec 31
Reports and events: 130 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2516:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-044305 |
| 2026-08-1716:05 ET | DEF 14A | Proxy statementPeriod 2026-08-17 | 0001493152-26-038740 |
| 2026-08-1308:32 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-037604 |
| 2026-08-1308:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-037600 |
| 2026-08-0708:30 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-036487 |
| 2026-06-2508:30 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-030037 |
| 2026-05-1508:36 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-023382 |
| 2026-05-1508:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-023376 |
| 2026-04-2208:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-018452 |
| 2026-04-0616:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-015297 |
| 2026-04-0108:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-014518 |
| 2026-03-3116:35 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-014236 |
| 2026-03-3116:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-014225 |
| 2026-03-2716:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-013198 |
| 2026-02-2408:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-007826 |
| 2026-02-1108:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-006122 |
| 2025-11-1808:36 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-023997 |
| 2025-11-1808:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-023996 |
| 2025-11-1008:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-021415 |
| 2025-11-0414:30 ET | 8-K/A | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-020708 |
| 2025-10-3108:30 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-020313 |
| 2025-10-2916:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-020059 |
| 2025-10-2016:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-018636 |
| 2025-09-2616:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-015709 |
| 2025-08-2916:38 ET | S-1/A | Registration statement, amended | 0001641172-25-026012 |
| 2025-08-2808:41 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-081405 |
| 2025-08-1816:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-077912 |
| 2025-08-1520:29 ET | DEF 14A | Proxy statementPeriod 2025-09-26 | 0001213900-25-076964 |
| 2025-08-1408:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-25-076059 |
| 2025-08-1316:11 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-075680 |
| 2025-08-1316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-075659 |
| 2025-07-2517:44 ET | S-1 | Registration statement | 0001641172-25-020890 |
| 2025-07-1716:05 ET | 8-K | 8.01 Other events | 0001213900-25-065139 |
| 2025-07-0716:10 ET | 8-K/A | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-061774 |
| 2025-07-0208:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-060712 |
| 2025-07-0108:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-059980 |
| 2025-06-3020:56 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-059196 |
| 2025-06-0316:30 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-050826 |
| 2025-05-2716:05 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-25-047800 |
| 2025-05-1508:51 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-043737 |
| 2025-05-1508:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-010538 |
| 2025-05-1316:05 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001641172-25-009942 |
| 2025-03-3108:37 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001213900-25-025791 |
| 2025-03-3108:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-025781 |
| 2025-03-1908:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-010871 |
| 2024-11-1506:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-046157 |
| 2024-11-1408:35 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-045377 |
| 2024-11-1408:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-045370 |
| 2024-11-0618:41 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-043703 |
| 2024-11-0117:24 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-043378 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.